BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Featured in Investment Research Report
Dec 9, 2022
BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, was featured in a recent report published by Zacks Small-Cap Research. In the report, Zacks valued BVXV at $57.00/ADS. The publication reads, “On November 30, 2022, BiondVax Pharmaceuticals Ltd. (BVXV) announced financial results for the third quarter of 2022 and provided a business update. The company recently announced positive preclinical results for its inhaled COVID-19 therapy. Using the industry-standard hamster model for COVID-19 therapeutics, results showed that hamsters treated with BiondVax’s NanoAb therapy had significantly (P<0.001) less weight loss than hamsters treated with placebo. In addition, eight other parameters, including heart rate and social behaviors, indicated that the group treated with the inhaled NanoAb experienced a shorter and milder illness. We anticipate additional data from this study in the first quarter of 2023. Assuming continued success, we expect BiondVax to initiate a Phase 1/2a clinical trial of the anti-COVID NanoAb in the fourth quarter of 2023.”
To view the full report, visit https://ibn.fm/U2fVx
About BiondVax Pharmaceuticals Ltd.
BiondVax is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. Since its inception, BiondVax has executed eight clinical trials including a seven country, 12,400 participant phase 3 trial of its prior vaccine candidate and has built a state-of-the-art manufacturing facility for biopharmaceutical products. With highly experienced pharmaceutical industry leadership, BiondVax is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized antibody (“NanoAb”) pipeline. For more information, visit the company’s website at www.BiondVax.com.
NOTE TO INVESTORS: The latest news and updates relating to BVXV are available in the company’s newsroom at https://ibn.fm/BVXV
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
Eat Your Way Through Latin America And We'll Tell You Which Hot Latine Celeb You Belong With (And Would Enjoy A Lovely Meal With)
I guarantee your mouth will be watering at the end of this quiz. View Entire Post ›
Way Too Many People Can't Pass A Simple Geography Test, And It's A Little Depressing
Test your knowledge of geography! View Entire Post ›
Hilary Swank, 52, is pregnant with her third child: 'This one releases in December'
Actress Hilary Swank, 52, has announced she's pregnant with her third child. It's the latest example of a growing trend in Canada and the U.S. of people choosing to have children later in life. But it's not without risks, one expert says.
20 Hours After Falling Overboard, Cruise Passenger Is Rescued Near Greece
According to Greek officials, the woman told her rescuers she had jumped off the ship because she “wanted to disembark.”
A More Dangerous World Is Changing the Rules of Business Travel
Medjet CEO John Gobbels explains why geopolitical shocks, strained health systems and changing security threats are forcing companies to rethink medical evacuation, crisis response and their duty of care. The post A More Dangerous World Is Changing the Rules of Business Travel appeared first on Business Traveller.
Holiday Travel 2026: What to Expect From Fares, Airports and Disruptions
Higher fares, Middle East disruption, fragile infrastructure and sharply changing travel patterns could make Christmas 2026 unusually difficult, as leisure and VFR demand redraw the world’s busiest airports and routes. The post Holiday Travel 2026: What to Expect From Fares, Airports and Disruptions appeared first on Business Traveller.
Facial Recognition is Transforming Airport Security – But Can Travelers Trust It?
Your boarding pass may soon be optional. Your face will not be. Airports are racing toward biometric travel, but every second saved creates a more complicated question about who holds the data. The post Facial Recognition is Transforming Airport Security – But Can Travelers Trust It? appeared first on Business Traveller.
We know junk food isn't healthy, but scientists are trying to determine if it's also bad for our brains
A new study co-authored by two researchers at Hamilton's McMaster University suggests brain health could be affected by consuming too much ultra-processed foods produced to be cheap and ready-to-eat.
UK Government to Review Airport Drop-Off Charges Following Surge in Fees
The 12-month review follows increases in drop-off fees of more than 40% by several airports this year The post UK Government to Review Airport Drop-Off Charges Following Surge in Fees appeared first on Business Traveller.
The best no-fly winter sun destinations: Blue-sky resorts you can reach by sail or rail - after low-cost airlines warn of rising fares
Desperate for some sunshine but fearing flights will be pricey in the wake of winter schedule cuts? Look no further than these plane-free travel routes...
Pink October in France: A toxic debate?
Pink October – the French version of Breast Cancer Awareness Month – is at the centre of a political storm here in France, after one MP said she refused to wear a pink ribbon, calling the month "utterly cynical". We dive into her reasoning, discuss the history of Breast Cancer Awareness Month, and learn how to look out for "pinkwashing".
Avoid a Lapland letdown! Experts reveal how to beat the stress of a Christmas trip - from finding cheap deals and choosing the right resort to guarding against the risk of no snow
It's never too early to prepare for Christmas - especially if you're planning to head to Lapland for a winter getaway.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.